Tag: Pharma News

Sequana Medical’s IND application to begin the phase 1/2a MOJAVE study with DSR 2.0 to treat congestive heart failure has been approved by the US FDA.

The US Food and Drug Administration (FDA) has approved Sequana Medical NV’s investigational new drug (IND) application for its second-generation DSR product (DSR 2.0) for the treatment of congestive heart failure. Sequana Medical NV is a pioneer in the treatment…

In order to better manage the rare disease Myasthenia gravis, UCB and Huma have partnered to develop digital health solutions.

With the support of their physician, patients with the uncommon disease Myasthenia gravis (MG) can better understand and manage their condition thanks to a partnership between UCB and Huma Therapeutics (Huma), a leading global digital health company and global biopharmaceutical…

Back to top

Registration Form


This will close in 0 seconds

WhatsApp Join Telegram